Tower Research Capital LLC (TRC) - EVELO BIOSCIENCES INC ownership

EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 50 filers reported holding EVELO BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of EVELO BIOSCIENCES INC
ValueSharesWeighting
Q1 2023$6
-33.3%
32,327
+507.7%
0.00%
Q4 2022$9
-99.9%
5,320
+0.7%
0.00%
Q3 2022$11,000
-15.4%
5,285
-11.2%
0.00%
Q2 2022$13,000
+30.0%
5,952
+108.3%
0.00%
Q1 2022$10,000
-75.0%
2,858
-57.2%
0.00%
-100.0%
Q4 2021$40,000
+25.0%
6,679
+46.4%
0.00%0.0%
Q3 2021$32,000
-3.0%
4,561
+91.0%
0.00%0.0%
Q2 2021$33,000
+57.1%
2,388
+24.3%
0.00%
Q1 2021$21,000
-48.8%
1,921
-44.0%
0.00%
-100.0%
Q4 2020$41,000
-53.4%
3,429
-79.6%
0.00%0.0%
Q3 2020$88,000
+486.7%
16,783
+459.4%
0.00%0.0%
Q2 2020$15,000
+650.0%
3,000
+408.5%
0.00%
Q1 2020$2,000
-71.4%
590
-65.8%
0.00%
-100.0%
Q4 2019$7,000
-70.8%
1,723
-57.5%
0.00%
-50.0%
Q3 2019$24,000
+2300.0%
4,057
+4170.5%
0.00%
Q2 2019$1,000
-97.4%
95
-98.0%
0.00%
-100.0%
Q1 2019$38,000
+40.7%
4,750
+129.0%
0.00%0.0%
Q4 2018$27,000
-43.8%
2,074
-47.2%
0.00%
-50.0%
Q3 2018$48,000
+140.0%
3,931
+128.8%
0.00%
+300.0%
Q2 2018$20,0001,7180.00%
Other shareholders
EVELO BIOSCIENCES INC shareholders Q4 2020
NameSharesValueWeighting ↓
HARBOURVEST PARTNERS LLC 3,063,505$37,038,00014.47%
Mayo Clinic 484,953$5,863,0007.05%
Flagship Pioneering Inc. 22,900,069$276,862,0005.04%
Trustees of Columbia University in the City of New York 113,850$1,376,0001.84%
Alphabet Inc. 1,060,495$12,821,0000.62%
Artal Group S.A. 700,000$8,463,0000.18%
Larson Financial Group LLC 28,353$343,0000.12%
PEDDOCK CAPITAL ADVISORS, LLC 3,663$44,0000.02%
CREDIT SUISSE AG/ 2,705,511$32,710,0000.02%
FMR LLC 6,803,365$82,253,0000.01%
View complete list of EVELO BIOSCIENCES INC shareholders